Suppr超能文献

抗逆转录病毒疗法的推广及其对乌干达按性别分列的结核报告趋势的影响。

Anti-retroviral therapy scale-up and its impact on sex-stratified tuberculosis notification trends in Uganda.

机构信息

The Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

J Int AIDS Soc. 2019 Sep;22(9):e25394. doi: 10.1002/jia2.25394.

Abstract

INTRODUCTION

In order to end the tuberculosis (TB) epidemic by 2035, countries must achieve a 10% annual decline in tuberculosis incidence rates by 2025. Provision of antiretroviral therapy (ART) has been associated with population level decreases in TB notification rates. We aimed to assess whether the progressive scale-up of ART provision over the past nine years has had an effect on population level trends of TB notification in Uganda stratified by sex and HIV status.

METHODS

The study area consisted of Kampala and eight surrounding districts. Annual TB notifications and mid-year populations were used to calculate notification rates per 100,000 population from the study area. Numbers alive and retained on ART were used to calculate ART coverage, overall and by sex. TB notification rates (TBNRs) overall and stratified by sex and HIV status were calculated for the period 2009 to 2017. Trends in TBNRs before and after rollout of universal ART for pregnant women in 2013 were examined using Poisson regression models. To gain insight into the trends in CD4+ T-cell counts at ART initiation over the study period, we performed a sub analysis of patient level data from the Infectious Diseases Institute clinic.

RESULTS

From 2009 to 2017, ART coverage increased by 27.6% among men and by 35.4% among women. TBNRs declined during the same period. Overall, the average annual percentage decline in TBNRs was -3.5% (95%CI -3.7% to -3.3%), (-2.3% (95%CI -2.6% to -1.9%) in men and -5.4% (95%CI -5.7% to -5.0%) in women). ART coverage increased after 2013 but this was not associated with an accelerated decline in overall TBNRs among HIV-positive persons -3.6% before 2013 and -5.2% after 2013; p = 0.33. The proportion of patients initiating ART with CD4+ T-cell count ≤ 200 cells/mL did not decrease significantly after 2013 (42.2% to 32.2%, p = 0.05).

CONCLUSIONS

Although ART scale-up was temporally associated with a decline in TB notification rates, the achieved rates of decline are below those required to achieve the End TB Targets. Additional investments in tuberculosis control should include efforts to promote earlier care seeking and ART initiation among HIV-positive persons.

摘要

引言

为了在 2035 年终结结核病(TB)流行,各国必须在 2025 年实现结核病发病率每年下降 10%。提供抗逆转录病毒疗法(ART)与结核病通报率的人群水平下降有关。我们旨在评估过去九年来 ART 提供的逐步扩大是否对乌干达按性别和 HIV 状况分层的结核病通报率的人群水平趋势产生了影响。

方法

研究区域包括坎帕拉和周围的八个区。使用研究区域的年度结核病通报数和年中人口数来计算每 10 万人的通报率。使用存活和继续接受 ART 的人数来计算 ART 覆盖率,总体和按性别计算。计算了 2009 年至 2017 年期间的整体和按性别和 HIV 状况分层的结核病通报率(TBNR)。使用泊松回归模型检查 2013 年为孕妇普遍提供 ART 前后 TBNR 的趋势。为了深入了解研究期间开始 ART 时 CD4+ T 细胞计数的趋势,我们对传染病研究所诊所的患者水平数据进行了亚分析。

结果

从 2009 年至 2017 年,男性的 ART 覆盖率提高了 27.6%,女性提高了 35.4%。同期 TBNR 下降。总体而言,TBNR 的年平均百分比下降率为-3.5%(95%CI-3.7%至-3.3%),(男性-2.3%(95%CI-2.6%至-1.9%),女性-5.4%(95%CI-5.7%至-5.0%))。2013 年后 ART 覆盖率增加,但这与 HIV 阳性人群总体 TBNR 的加速下降无关-2013 年前为-3.6%,2013 年后为-5.2%;p=0.33。2013 年后,开始 ART 时 CD4+ T 细胞计数≤200 个/μL 的患者比例没有显著下降(42.2%降至 32.2%,p=0.05)。

结论

尽管 ART 规模的扩大与结核病通报率的下降有关,但实现的下降率低于实现终止结核病目标所需的下降率。结核病控制方面的额外投资应包括努力促进 HIV 阳性人群更早寻求护理和开始接受 ART。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验